SAN DIEGO, Feb. 11, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) said that on Wednesday, February 13, 2002 the Company will release its financial results for the fourth quarter and twelve months ended December 31, 2001. Edward F. Calesa, chairman, president and CEO, and Charles M. Caporale, vice president and CFO, will host a conference call that same day at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) to discuss the Company's financial results. Discussions may contain forward-looking and other material information.
Access Instructions:
The February 13 conference call will be available to all interested parties through a live audio Web broadcast via the Internet at Women First's website, www.womenfirst.com, at CCBN's www.companyboardroom.com (Windows Media Player), and at World Investor Link's www.vcall.com (RealPlayer).
Replay Option Available Until February 27, 2002:
Audio-only via Internet: The call will be archived and available on the above websites for two weeks beginning 12:00 p.m., EST, Wednesday, February 13, through 5:00 p.m., EST, Wednesday, February 27.
Audio-only via Telephone: A telephone replay of the call will also be available from 12:00 p.m., EST, Wednesday, February 13, through 5:00 p.m., EST, Wednesday, February 27. Please call (800) 642-1687 (domestic) or (706) 645-9291 (international) and use conference pass code No. 3214846.
For further information please contact Diane Donohue, Director, Public Relations, Women First HealthCare, Inc., (858) 509-3860, ddonohue@womenfirst.com.
About Women First HealthCare, Inc.
Women First HealthCare, Inc. (Nasdaq:WFHC) is a San Diego-based specialty pharmaceutical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceutical products-the Company's primary emphasis-and lifestyle products to meet their needs. Women First HealthCare is specifically targeted to women age 40+ and their clinicians. An internationally recognized Health Advisory Board of experts in women's health guides Women First HealthCare in the development of information and products for women and clinicians as women transition from perimenopause through postmenopause. The Company operates in three segments: Pharmaceuticals, Consumer Business, and Corporate Marketing. Product focus currently includes estrogen replenishment, headache/pain management, antibacterial/urinary tract infection management, dietary supplementation, and self-care/lifestyle. Further information about Women First HealthCare can be found online at www.womenfirst.com, About Us and Investor Relations. Information about the Company's As We Change(r) national mail order catalog and Internet retailer can also be found online at www.aswechange.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to various risks, and Women First HealthCare, Inc. cautions you that any forward-looking information is not a guarantee of future performance. Women First HealthCare, Inc. disclaims any intent or obligation to update these forward-looking statements. Actual results could differ materially due to a number of factors, including (i) we have incurred significant losses since we were founded in November 1996, and if midlife women do not use, and their clinicians do not recommend, the products we offer, we will continue to experience losses; (ii) there is a limited market awareness of our Company and the products and services we offer; (iii) we may not be able to identify appropriate licensing, co-promotion or acquisition candidates in the future or to take advantage of the opportunities we identify; (iv) we and our products face significant competition; (v) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (vi) we are dependent on single sources of supply for all of the products we offer; (vii) reduced consumer confidence could adversely affect sales by our Consumer Business Division; and (viii) additional factors set forth in the Company's Securities and Exchange Commission filings including its Annual Report on Form 10-K for the period ended December 31, 2000 and its Form 10-Q for the period ended September 30, 2001.